Work

Efficacy and Safety of Carfilzomib-Lenalidomide-Dexamethasone (KRd) in Newly Diagnosed Multiple Myeloma: Pooled Analysis of 4 Single-Arm Studies

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-127076

Authors: Ola Landgren, Michel Attal, Dickran Kazandjian, Murielle Roussel, Jagoda K. Jasielec, Dominik Dytfeld, Aparna Anderson, Tara Kervin, Karim Iskander, Khalid Mezzi, Tim Welliver, Akeem Yusuf, Andrzej Jakubowiak

Institutions: Memorial Sloan Kettering Cancer Center, Institut universitaire du cancer de Toulouse Oncopole, National Institutes of Health, National Cancer Institute, Center for Cancer Research, Centre Hospitalier Universitaire de Toulouse, University of Chicago, Poznan University of Medical Sciences, Statistics Collaborative, Amgen (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2988703864

Cites:

Cited by: 3

Related to: 10